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Case Reportsinterference on computed tomography and MRI when used
during follow-up, and it is easy to perform. Combined with
a mesh or muscular flap, it provides both airtight and water-
tight closure of the chest wall.
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2009;87:e46-8.Transapical aortic valve (JenaValve) implantation for severe aortic
insufficiency and aortic aneurysmFriederike Schlingloff, MD, Christian Frerker, MD, Ulrich Sch€afer, MD, and Ralf Bader, MD, Hamburg,
GermanyTransapical transcatheter aortic valve implantation has
become a valid treatment option for severe aortic stenosis
in patients who are at high risk or are not operative candi-
dates.1 Various self-expanding (CoreValve; Medtronic Inc,
Minneapolis, Minn) or balloon-inflatable (Sapien XT;
Edwards Inc, Irvine, California) valves are currently widely
used. Recently, transcatheter aortic valve implantation has
also been used to treat pure aortic regurgitation.2 Several
cases in which the CoreValve has successfully been used
have been reported.3,4 Because conventional transcatheter
aortic valve implantation prostheses usually need
calcification of the native valve for anchoring, however,
their use is limited and not free of device embolization.
The JenaValve (JenaValve Technology GmbH, Munich,
Germany) is a self-expandable valve with 3 metal feelers
that allows anatomically correct positioning within the
native valve and can be used in a transapical approach.
The probe elements are placed into the native cusps, and
the valve is then clipped onto the leaflets with a ‘‘paper
clip’’ mechanism and released from the catheter. No
rapid-pacing is needed, because the valve is instantly fully
functional. The JenaValve does not need calcification of
the native valve for anchoring of the prosthesis and thus
seems well suited for the use in pure aortic regurgitation.Its value in treating aortic stenosis has been shown in recent
publications.5 Treatment of aortic regurgitation in combina-
tion with aortic aneurysm usually warrants aortic root
replacement, however, with aortic valve replacement as a
conventional open procedure. We report a case of the suc-
cessful use of the transapical JenaValve as an off-label
approach in a patient with pure aortic insufficiency and
aortic aneurysm.FIGURE 1. After the valve was directly inserted into the annulus, the
feelers were exposed and positioned at the base of the aortic cusps with
fluoroscopic confirmation.
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FIGURE 2. On deployment, the nitinol stent expanded and was safely
anchored in the native valve annulus.
Case ReportsCLINICAL SUMMARY
A 70-year-old woman presented at our institution with
acute cardiac failure from severe aortic regurgitation. A
multislice spiral computed tomographic scan revealed an
aneurysm of the ascending aorta as large as 56 mm in diam-
eter. There was no coronary artery disease visible on angi-
ography. With a euroSCORE II of 5.5% and a Society of
Thoracic Surgeons score of 13%, the patient clearly had
no indication for a transcatheter procedure. During discus-
sions, however, the patient persistently refused cardiac sur-
gery, even when confronted with the risk of progress and
possible rupture of the aneurysm. It became clear that the
patient had been admitted to another department of cardiac
surgery before, where surgery had been discussed and she
had also refused it. The patient had left that hospital against
medical advice. After further discussion with cardiac sur-
geons and cardiologists of the heart team, the patient would
only agree to a transcatheter approach. A transapical valve
implantation was planned to reduce ‘‘contact’’ with the
ascending aorta to a minimum.
The procedure was performed in the hybrid operating
room with a team consisting of cardiologists and cardiotho-
racic surgeons. The transapical access was prepared in the
typical way. The apex was punctured in the middle of the
purse-string sutures, and a regular J-wire was introduced
with successive insertion of a 6F sheath. Because of the
complex anatomy, 2 pigtail catheters were introduced forThe Journal of Thoracic and Cabetter visualization. Valvuloplasty was omitted, and the
valve was directly inserted into the annulus. Subsequently,
the feelers were exposed and placed at the base of the aortic
cusps. Correct positioning was confirmed on fluoroscopy
(Figure 1). In a second step, the prosthesis was deployed
during accelerated pacing (120 beats/min). The nitinol stent
expanded and was safely anchored in the native valve
annulus (Figure 2). No paravalvular leak was found on im-
mediate echocardiographic and angiographic control. The
chest wall and incision were closed in routine fashion.
The patient was in hemodynamically stable condition
immediately after the procedure and was brought to the
intensive care unit. Discharge from the hospital was
possible on the 9th postoperative day without any complica-
tions. Repeated echocardiographic controls demonstrated a
persistent excellent result with no leak.
DISCUSSION
In this case, there was no indication for a transcatheter
procedure other than the patient’s definite refusal of an
open procedure. Progression of the aneurysm is likely,
although there could be a stabilizing effect through a dimin-
ished pressure amplitude after valve implantation. We still
believe that the transcatheter approach should be restricted
to the original group of patients who are not operative can-
didates or who face a high risk during conventional open
surgery. With second-generation valves such as the Jena-
Valve, there could be an expanding landscape of indications
in the future. The special clip mechanism of the JenaValve
is an appealing concept for patients without calcification of
the aortic cusps. Implantation of the JenaValve, as shown in
this case, seems uncomplicated, because the feelers enable
exact and anatomically correct positioning. Nevertheless,
long-term data on the performance of these valves in these
particular patients is needed for the future.References
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